Literature DB >> 15309885

C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma.

Chikao Miki1, Naomi Konishi, Eiki Ojima, Tsuyoshi Hatada, Yasuhiro Inoue, Masato Kusunoki.   

Abstract

Up-regulation of the IL-1-IL-6 network stimulates systemic expression of C-reactive protein (CRP). This cytokine network system plays a pivotal role in inducing angiogenic growth factors in intestinal mucosa. Serum CRP level and tissue concentrations of cytokines in colorectal cancer patients were determined and an in vitro model was employed to determine the time course of induction of IL-6 in Caco-2 cells. Increased serum CRP was associated with recurrent disease and shorter survival time. Intense surgical stress and the presence of an acute phase reactant were independently associated with overexpression of IL-6 in the tumor. Enhanced IL-6 protein expression in Caco-2 cells induced by the initial treatment with IL-1beta or lipopolysaccharide could be abrogated by additional presupplementation of IL-1ra. The presence of an acute phase reactant reflects uncontrolled up-regulation of the local IL-1-IL-6 network system in the tumor, which may enhance the survival and proliferation of remnant cancer cells after tumor resection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309885     DOI: 10.1023/b:ddas.0000034556.48527.6e

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis.

Authors:  M A Frassanito; A Cusmai; G Iodice; F Dammacco
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

Review 2.  Function of C-reactive protein.

Authors:  T W Du Clos
Journal:  Ann Med       Date:  2000-05       Impact factor: 4.709

3.  Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells.

Authors:  D Chauhan; S Kharbanda; A Ogata; M Urashima; G Teoh; M Robertson; D W Kufe; K C Anderson
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

4.  The influence of interleukin-6 on the growth of human esophageal cancer cell lines.

Authors:  M Oka; N Iizuka; K Yamamoto; T Gondo; T Abe; S Hazama; Y Akitomi; Y Koishihara; Y Ohsugi; Y Ooba; T Ishihara; T Suzuki
Journal:  J Interferon Cytokine Res       Date:  1996-12       Impact factor: 2.607

5.  Association between preoperative acute phase response and postoperative complications.

Authors:  W Haupt; W Hohenberger; R Mueller; P Klein; N V Christou
Journal:  Eur J Surg       Date:  1997-01

6.  An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma.

Authors:  Z Y Lu; R Bataille; P Poubelle; M J Rapp; J L Harousseau; B Klein
Journal:  Stem Cells       Date:  1995-08       Impact factor: 6.277

7.  A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery.

Authors:  D C McMillan; H A Wotherspoon; K C Fearon; C Sturgeon; T G Cooke; C S McArdle
Journal:  Am J Surg       Date:  1995-10       Impact factor: 2.565

8.  Prognostic value of preoperative serum immunosuppressive acidic protein in patients with esophageal squamous cell carcinoma.

Authors:  H Shimada; Y Nabeya; S Okazumi; H Matsubara; Y Miyazawa; T Shihratori; H Hayashi; T Aoki; M Sugaya; Y Gunji; S Kobayashi; T Ochiai
Journal:  Dis Esophagus       Date:  2003       Impact factor: 3.429

9.  Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: possible influence of p53 but not human papillomavirus E6/E7.

Authors:  K V Woods; K Adler-Storthz; G L Clayman; G M Francis; E A Grimm
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

10.  Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease.

Authors:  F Riché; C Dosquet; Y Panis; P Valleur; M J Laisné; C Briard; J L Wautier
Journal:  J Am Coll Surg       Date:  1995-06       Impact factor: 6.113

View more
  37 in total

1.  Systemic inflammatory response associated with distant metastasis of T1 or T2 colorectal cancer.

Authors:  Mitsuru Ishizuka; Hitoshi Nagata; Kazutoshi Takagi; Keiichi Kubota
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

2.  Pro-inflammatory cytokine interleukin-1β promotes the development of intestinal stem cells.

Authors:  Lei Wang; Ziyan Liu; Yijing Li; Loretta Pappan; Amy Galliher-Beckley; Jishu Shi
Journal:  Inflamm Res       Date:  2012-06-16       Impact factor: 4.575

3.  Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.

Authors:  Yuji Toiyama; Chikao Miki; Yasuhiro Inoue; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

4.  IL-1β promotes proliferation and migration of gallbladder cancer cells via Twist activation.

Authors:  Runsheng Guo; Yiyu Qin; Peidong Shi; Jinbi Xie; Ming Chou; Yueyu Chen
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

Review 5.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

6.  Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.

Authors:  Tadanobu Shimura; Yuji Toiyama; Susumu Saigusa; Hiroki Imaoka; Masato Okigami; Hiroyuki Fujikawa; Junichiro Hiro; Minako Kobayashi; Masaki Ohi; Toshimitsu Araki; Yasuhiro Inoue; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  Int J Clin Oncol       Date:  2017-03-15       Impact factor: 3.402

7.  Clinical relevance of the number of interleukin-17-producing CD 8+ T cells in patients with gastric cancer.

Authors:  Hiroaki Saito; Yoshinori Yamada; Seigo Takaya; Tomohiro Osaki; Masahide Ikeguchi
Journal:  Surg Today       Date:  2015-04-14       Impact factor: 2.549

8.  Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Eiji Noda; Hiroshi Ohtani; Yukio Nishiguchi; Kosei Hirakawa
Journal:  Surg Today       Date:  2014-05-10       Impact factor: 2.549

9.  Serum C-reactive protein and risk of lung cancer: a case-control study.

Authors:  Ming Xu; Minglin Zhu; Yinggan Du; Bibo Yan; Qian Wang; Cong Wang; Jinping Zhao
Journal:  Med Oncol       Date:  2012-12-15       Impact factor: 3.064

Review 10.  Perioperative host-tumor inflammatory interactions: a potential trigger for disease recurrence following a curative resection for colorectal cancer.

Authors:  Chikao Miki; Kouji Tanaka; Yasuhiro Inoue; Toshimitsu Araki; Masaki Ohi; Yasuhiko Mohri; Keiichi Uchida; Masato Kusunoki
Journal:  Surg Today       Date:  2008-07-09       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.